HMGB1

High mobility group protein B1 UniProt accession P09429

Multifunctional redox sensitive protein with various roles in different cellular compartments. In the nucleus is one of the major chromatin-associated non-histone proteins and acts as a DNA chaperone involved in replication, transcription, chromatin remodeling, V(D)J recombination, DNA repair and genome stability (PubMed:33147444). Proposed to be an universal biosensor for nucleic acids.

Promotes host inflammatory response to sterile and infectious signals and is involved in the coordination and integration of innate and adaptive immune responses. In the cytoplasm functions as a sensor and/or chaperone for immunogenic nucleic acids implicating the activation of TLR9-mediated immune responses, and mediates autophagy. Acts as a danger-associated molecular pattern (DAMP) molecule that amplifies immune responses during tissue injury (PubMed:27362237).

Released to the extracellular environment can bind DNA, nucleosomes, IL-1 beta, CXCL12, AGER isoform 2/sRAGE, lipopolysaccharide (LPS) and lipoteichoic acid (LTA), and activates cells through engagement of multiple surface receptors (PubMed:34743181). In the extracellular compartment fully reduced HMGB1 (released by necrosis) acts as a chemokine, disulfide HMGB1 (actively secreted) as a cytokine, and sulfonyl HMGB1 (released from apoptotic cells) promotes immunological tolerance (PubMed:23446148, PubMed:23519706, PubMed:23994764, PubMed:25048472). Has proangiogdenic activity (By similarity).

May be involved in platelet activation (By similarity). Binds to phosphatidylserine and phosphatidylethanolamide (By similarity). Bound to RAGE mediates signaling for neuronal outgrowth (By similarity).

May play a role in accumulation of expanded polyglutamine (polyQ) proteins such as huntingtin (HTT) or TBP (PubMed:23303669, PubMed:25549101)

Source: UniProt

Interacts (fully reduced HMGB1) with CXCL12; probably in a 1:2 ratio involving two molecules of CXCL12, each interacting with one HMG box of HMGB1; inhibited by glycyrrhizin (PubMed:22370717). Associates with the TLR4:LY96 receptor complex (PubMed:20547845). Component of the RAG complex composed of core components RAG1 and RAG2, and associated component HMGB1 or HMGB2 (By similarity).

Interacts (in cytoplasm upon starvation) with BECN1; inhibits the interaction of BECN1 and BCL2 leading to promotion of autophagy (PubMed:20819940). Interacts with KPNA1; involved in nuclear import (PubMed:17114460). Interacts with SREBF1, TLR2, TLR4, TLR9, PTPRZ1, APEX1, FEN1, POLB, TERT (By similarity).

Interacts with IL1B, AGER, MSH2, XPA, XPC, HNF1A, TP53 (PubMed:15014079, PubMed:18160415, PubMed:18250463, PubMed:19446504, PubMed:23063560, PubMed:24474694). Interacts with CD24; the probable CD24:SIGLEC10 complex is proposed to inhibit HGMB1-mediated tissue damage immune response (PubMed:19264983). Interacts with THBD; prevents HGMB1 interaction with ACER/RAGE and inhibits HGMB1 pro-inflammatory activity (PubMed:15841214).

Interacts with HAVCR2; impairs HMGB1 binding to B-DNA and likely HMGB1-mediated innate immune response (By similarity). Interacts with XPO1; mediating nuclear export (By similarity). Interacts with HTT (wild-type and mutant HTT with expanded polyglutamine repeat) (PubMed:23303669).

Interacts with receptor RAGE/AGER (PubMed:34743181)

(Microbial infection) Interacts with adenovirus protein pVII; this interaction immobilizes HMGB1 on chromatin, thus preventing its release from cell and subsequent inflammation activation

(Microbial infection) Interacts with SARS-CoV-2 ORF3A protein; the interaction promotes association of HMGB1 with BECN1, promoting reticulophagy which induces endoplasmic reticulum stress and inflammatory responses and facilitates viral infection

(Microbial infection) Interacts with influenza A virus protein NP; this interaction promotes viral replication

Source: UniProt
Nucleus, Chromosome, Cytoplasm, Secreted, Cell membrane — Peripheral membrane protein, Endosome, Endoplasmic reticulum-Golgi intermediate compartment Endoplasmic reticulum
Source: UniProt

Ubiquitous. Expressed in platelets (PubMed:11154118)

Source: UniProt

HMG box 2 mediates pro-inflammatory cytokine-stimulating activity and binding to TLR4 (PubMed:12765338, PubMed:20547845). However, not involved in mediating immunogenic activity in the context of apoptosis-induced immune tolerance (PubMed:24474694)

The acidic C-terminal domain forms a flexible structure which can reversibly interact intramolecularily with the HMG boxes and modulate binding to DNA and other proteins (PubMed:23063560)

Source: UniProt
  • ER-Phagosome pathway
  • Apoptosis induced DNA fragmentation
  • MyD88:MAL(TIRAP) cascade initiated on plasma membrane
  • TAK1-dependent IKK and NF-kappa-B activation
  • MyD88 deficiency (TLR2/4)
  • IRAK4 deficiency (TLR2/4)
  • Pyroptosis
  • Regulation of TLR by endogenous ligand
  • Neutrophil degranulation
  • Advanced glycosylation endproduct receptor signaling
  • TRAF6 mediated NF-kB activation
Source: Reactome via UniProt

Mutations

No mutation information available.

Synthetic Lethal Network

Genes with an experimentally identified or computationally predicted synthetic-lethal relationship to HMGB1, aggregated across our SSL data sources. Click any partner node to view that gene’s page.

Nodes and edges are coloured by the SSL data source. Partners appearing in more than one source are shown in grey.

BioGRID SLOrth SynLethDB MexDrugs Multi-source
Sources: BioGRID, SLOrth, SynLethDB, MexDrugs

Clinical Trials

Total Trials Found: 20

NCT ID Condition Brief Title Phase Status
NCT05555537 Drug Resistant Epilepsy MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy N/A UNKNOWN
NCT06649474 Pancreatic Cancer, Resectable Pancreatic Adenocarcinoma, Adenocarcinoma, Resectable Esophageal Cancer, Resectable Gastric or Gastroesophageal Junction Adenocarcinoma, Oesophagogastric Cancer Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1 NA RECRUITING
NCT03535441 Intensive Care Unit, Hemorrhagic Shock, Adult Disease HMGB1 Release From Hemorrhagic Shock Patients N/A COMPLETED
NCT05795192 Safety Issues, Tolerability, Pharmacokinetics, Pharmacodynamics SB17170 Phase1 Trial in Healthy Volunteer PHASE1 COMPLETED
NCT02964624 Osteoarthritis Ostearthritis Biomarkers and Rehabilitation NA COMPLETED
NCT06986837 Sickle Cell Disease Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient N/A COMPLETED
NCT06971770 Periodontal Diseases EVALUATION OF SALIVARY BİOMARKER LEVELS IN SMOKING AND NON-SMOKER INDIVIDUALS WITH DIFFERENT PERIODONTAL DISEASES NA COMPLETED
NCT01270295 Acute Lung Injury, Acute Respiratory Distress Syndrome, Mechanical Ventilation Soluble Forms and Ligands of RAGE in ALI/ARDS (SoLiRAGE). N/A COMPLETED
NCT02490644 Valvular Heart Disease Role of High Mobility Group Box 1 as a Prognostic Biomarker in Patients Undergoing Valvular Heart Surgery N/A COMPLETED
NCT04837391 Postoperative Cognitive Dysfunction, Postoperative Delirium, Frailty Postoperative Cognitive Dysfunction in Elderly Urologic Oncology Patients (POCD) N/A UNKNOWN